new diorganotin(iv) complexes of the type ph2snl2, bu2snl2 and me2snl2 of the ligands 2-thioacetic-5-phenyl-1,3,4-oxadiazole (hl1) and benzamidophenylalanine (hl2). have been synthesized and characterized by physico-chemical techniques such as (elemental analysis, and electrolytic conductance) and spectral uv-visible, ir and 1h, 13c and 119sn nmr). monomer structures for the complexes, bidentat...

Synthesis of 4-(N,N- dimethylamino)-3-aryl-3-butene-2-one, ethyl-5-aryl-4-oxo-4H-pyran-2-carboxylate, ethyl-5-aryl-4-pyridones-2-carboxylate and 5-aryl-3-cyano-5-methyl-2-pyridones (aryl=3-thienyl, 2-furyl) are described.

the melt-phase synthesis of dioctyltin (iv) and triphenyltin (iv) benzoates were carried outusing stoichiometric amounts of benzoic acids and the corresponding organotin (iv) compounds.the reagents were ground together in a mortar and fed into a boiling glass tube. a cannula tubewas inserted into the boiling tube to discharge accumulated gaseous products. a syringe ensureda continuous flow of d...

Pyrroline-5-carboxylate, the intermediate in the interconversion of proline, ornithine, and glutamate, increases 5-phosphoribosyl 1-pyrophosphate (PP-ribose-P) and purine nucleotide formation in intact human erythrocytes. We proposed that: 1) pyrroline-5-carboxylate is converted to proline by pyrroline-5-carboxylate reductase with concomitant oxidation of NADPH, 2) NADP+ augments glucose-6-phos...

synthesis of 4-(n,n- dimethylamino)-3-aryl-3-butene-2-one, ethyl-5-aryl-4-oxo-4h-pyran-2-carboxylate, ethyl-5-aryl-4-pyridones-2-carboxylate and 5-aryl-3-cyano-5-methyl-2-pyridones (aryl=3-thienyl, 2-furyl) are described.

abstract: two new transition metal complexes, containing the acidic ligand 5-chlorosalicylic acid (h2l5), and 1,10-phenanthroline（phen） and 1,3-di(4-pyridyl)propane (bpp) as secondary ligands are reported. they are formulated as {[pb(hl5)2(phen)(h2o)]·h2o}n(1), [zn2(hl5)4(bpp)2]n(2). all the complexes are characterized by single-crystal x-ray diffractions. compoud 1 crystallizes in the triclini...

Reaction of methyl 3-bromo-5-cyanoisothiazole-4-carboxylate with conc. H2SO4 gave 3-bromo-5-carbamoylisothiazole-4-carboxylate in 93% yield. The compound was fully characterized.

Oseltamivir carboxylate is a potent and specific inhibitor of influenza neuraminidase (NA). An influenza A/H1N1 variant selected in vitro with reduced susceptibility to oseltamivir carboxylate contains a His274Tyr mutation. To understand the mechanism by which a His274Tyr mutation gives rise to drug resistance, we studied a series of NA variant proteins containing various substitutions at posit...

Oseltamivir, a potent and selective inhibitor of influenza A and B virus neuraminidases, is a prodrug that is systemically converted into the active metabolite oseltamivir carboxylate. In light of reported neuropsychiatric events in influenza patients, including some taking oseltamivir, and as part of a full assessment to determine whether oseltamivir could contribute to, or exacerbate, such ev...

AIMS The aims of the present study were to compare the pharmacokinetics of oseltamivir and its active antiviral metabolite oseltamivir carboxylate in obese and non-obese individuals and to determine the effect of obesity on the pharmacokinetic properties of oseltamivir and oseltamivir carboxylate. METHODS The population pharmacokinetic properties of oseltamivir and oseltamivir carboxylate wer...